Using antithrombotic therapy in ischemic cerebrovascular disease.
D001241:Aspirin / Q000627:therapeutic use; D001921:Brain / Q000098:blood supply; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004176:Dipyridamole / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002542:Intracranial Embolism and Thrombosis / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy; D013442:Sulfinpyrazone / Q000627:therapeutic use; D014859:Warfarin / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D014859:Warfarin; D004176:Dipyridamole; D006493:Heparin; D001241:Aspirin; D013442:Sulfinpyrazone